PF-04691502

PF-04691502
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-P2002.1 1 mg -

3 - 8 business days*

180.00€
LKT-P2002.5 5 mg -

3 - 8 business days*

325.00€
LKT-P2002.10 10 mg -

3 - 8 business days*

518.00€
 
PF-04691502 inhibits PI3K and mTORC1/2, exhibiting anticancer chemotherapeutic and... more
Product information "PF-04691502"
PF-04691502 inhibits PI3K and mTORC1/2, exhibiting anticancer chemotherapeutic and anti-angiogenic activities. In nasopharyngeal carcinoma cells, PF-04691502 induces G0/G1 cell cycle arrest and apoptosis, inhibiting proliferation. In similar animal models, PF-04691502 decreases tumor volume and weight. Additionally, PF-04691502 decreases tumor growth of bladder cancer tumors in vivo and decreases VEGF secretion and cell proliferation in vitro.
Supplier: LKT Laboratories
Supplier-Nr: P2002

Properties

Application: PI3K and mTOR inhibitor
MW: 461.51 D
Purity: >98%
Format: Solid

Database Information

CAS : 1013101-36-4| Matching products
KEGG ID : K07203 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "PF-04691502"
Write a review
or to review a product.
Viewed